Bae, S.H.; Choi, H.G.; Park, S.Y.; Chang, S.-Y.; Kim, H.; Kim, S.H.
Effects of Isosakuranetin on Pharmacokinetic Changes of Tofacitinib in Rats with N-Dimethylnitrosamine-Induced Liver Cirrhosis. Pharmaceutics 2022, 14, 2684.
https://doi.org/10.3390/pharmaceutics14122684
AMA Style
Bae SH, Choi HG, Park SY, Chang S-Y, Kim H, Kim SH.
Effects of Isosakuranetin on Pharmacokinetic Changes of Tofacitinib in Rats with N-Dimethylnitrosamine-Induced Liver Cirrhosis. Pharmaceutics. 2022; 14(12):2684.
https://doi.org/10.3390/pharmaceutics14122684
Chicago/Turabian Style
Bae, Sung Hun, Hyeon Gyeom Choi, So Yeon Park, Sun-Young Chang, Hyoungsu Kim, and So Hee Kim.
2022. "Effects of Isosakuranetin on Pharmacokinetic Changes of Tofacitinib in Rats with N-Dimethylnitrosamine-Induced Liver Cirrhosis" Pharmaceutics 14, no. 12: 2684.
https://doi.org/10.3390/pharmaceutics14122684
APA Style
Bae, S. H., Choi, H. G., Park, S. Y., Chang, S.-Y., Kim, H., & Kim, S. H.
(2022). Effects of Isosakuranetin on Pharmacokinetic Changes of Tofacitinib in Rats with N-Dimethylnitrosamine-Induced Liver Cirrhosis. Pharmaceutics, 14(12), 2684.
https://doi.org/10.3390/pharmaceutics14122684